A Phase 2 Trial Testing ZP1848 in Patients With SBS

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
A proof-of-concept, dose finding, controlled, single-center, randomized, double-blind, fixed dose phase 2 trial with ZP1848 in patients with Short Bowel Syndrome.
Epistemonikos ID: 9effbb2d38de4f4cfcc011d755c12b8c3b2cd608
First added on: May 12, 2024